Total Funding
80
43
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3072722
AngioGenex is a biopharmaceutical company dedicated to the development of treatment for vascular diseases.
Edmon Jennings: President, Chief Executive Officer and Board MemberPast Role: AngioGenex, President & CEO
About the Company
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
